EXCLUSIVE: Hudson Williams first made the switch from smoking cigarettes to vaping in 2019 because it 'tasted better' but a ...

While brisk walks may not technically increase lung capacity, they can train your lungs and the cardiovascular system and ...

A Bolton woman is walking one mile a day in October to honour three family members lost to lung cancer. Megan Turner, who has ...

Cawood was unafraid to challenge the region’s powerful coal industry as an attorney and one-term state legislator.

While it wasn't clear whether Keaton had any underlying conditions, doctors say "perfectly healthy" people can die from ...

In light of new data at ESMO, researchers debated whether HER2-targeted tyrosine kinase inhibitors or antibody-drug conjugates might be better as initial treatment.

Enhertu significantly improved IDFS compared to Kadcyla, with a 53% risk reduction in invasive disease or death in high-risk, ...

Tiragolumab plus atezolizumab did not improve progression-free survival compared to durvalumab in stage III NSCLC patients post-cCRT. Median progression-free survival and overall survival were similar ...

Invikafusp alfa demonstrated significant antitumor activity in TMB-H and MSI-H tumors resistant to immune checkpoint blockade, with ORRs ranging from 20.5% to 33.3%. The trial's safety profile was ...

Among patients with small cell lung cancer (SCLC), treatment with Imdelltra (tarlatamab-dlle) was found to improve overall ...

BERLIN -- Almost half of patients with advanced ALK -positive non-small cell lung cancer (NSCLC) have lived 7 years or longer ...

Positive results for Hernexeos (zongertinib) as a first-line treatment for non-small cell lung cancer (NSCLC) with HER2 mutations were reported yesterday at the European Society for Medical Oncology ...